col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Portland Press
  original article Journal Date Title Authors All Authors
1 [GO] Biochemical Journal 2021―Sep―24 Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain Jessie L Gan, Ruiqi Huang, Abigail Kelley, Gabrielle Warner, Duncan McGregor, Vaughn V. Smider
2 [GO] Bioscience Reports 2021―Sep―14 Targeting Intra-Viral Conserved Nucleocapsid (N) Proteins as Novel Vaccines against SARS-CoVs Min Thura, Joel Xuan En Sng, Koon Hwee Ang, Jie Li, Abhishek Gupta, Jimmy Ming Hong, et al. (+2)
3 [GO] The Biochemist 2021―Aug―23 Crowd sourcing yeast and rising above the pandemic: the SuperYeast project survival tale Naomi Wilkinson
4 [GO] Biochemical Journal 2021―Aug―13 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease Berta Canal, Allison W. McClure, Joseph F. Curran, Mary Wu, Rachel Ulferts, Florian Weissmann, et al. (+13)
5 [GO] Bioscience Reports 2021―Aug―05 Obesity, a major risk factor for immunity and severe outcomes of COVID-19 Mohammad Tohidul Amin, Kaniz Fatema, Sayama Arefin, Fahad Hussain, Dipty Rani Bhowmik, Mohammad Salim Hossain
6 [GO] Biochemical Society Transactions 2021―Aug―05 Host ADP-ribosylation and the SARS-CoV-2 macrodomain Nicolas C. Hoch
7 [GO] Clinical Science 2021―Aug―02 Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility Nayara Azinheira Nobrega Cruz, Danielle Stoll, Dulce Elena Casarini, Mariane Bertagnolli
8 [GO] Bioscience Reports 2021―Jul―30 SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19 Lize M Grobbelaar, Chantelle Venter, Mare Vlok, Malebogo Ngoepe, Gert J Laubscher, Petrus J Lourens, et al. (+3)
9 [GO] Essays in Biochemistry 2021―Jul―30 Roles of steroid receptors in the lung and COVID-19 Damien A. Leach, Greg N. Brooke, Charlotte L. Bevan
10 [GO] Bioscience Reports 2021―Jul―27 A lipidomic view of SARS-CoV-2 Kourosh Honarmand Ebrahimi, James McCullagh
11 [GO] Bioscience Reports 2021―Jul―22 Biochemical composition, transmission and diagnosis of SARS-CoV-2 Rajesh Ahirwar, Sonu Gandhi, Komal Komal, Geeta Dhaniya, Prem Prakash Tripathi, Vyas Madhavrao Shingatgeri, et al. (+3)
12 [GO] Biochemical Journal 2021―Jul―01 Author's overview: identifying SARS-CoV-2 antiviral compounds John F.X. Diffley
13 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease Chew Theng Lim, Kang Wei Tan, Mary Wu, Rachel Ulferts, Lee A. Armstrong, Eiko Ozono, et al. (+13)
14 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase Souradeep Basu, Tiffany Mak, Rachel Ulferts, Mary Wu, Tom Deegan, Ryo Fujisawa, et al. (+15)
15 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase Jingkun Zeng, Florian Weissmann, Agustina P. Bertolin, Viktor Posse, Berta Canal, Rachel Ulferts, et al. (+13)
16 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase Agustina P. Bertolin, Florian Weissmann, Jingkun Zeng, Viktor Posse, Jennifer C. Milligan, Berta Canal, et al. (+6)
17 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease Jennifer C. Milligan, Theresa U. Zeisner, George Papageorgiou, Dhira Joshi, Christelle Soudy, Rachel Ulferts, et al. (+16)
18 [GO] Biochemical Journal 2021―Jul―01 Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease Berta Canal, Ryo Fujisawa, Allison W. McClure, Tom D. Deegan, Mary Wu, Rachel Ulferts, et al. (+8)
19 [GO] Biochemical Journal 2021―Jul―01 An all-out assault on SARS-CoV-2 replication Ronald T. Hay
20 [GO] Bioscience Reports 2021―Jul―01 Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 Aline H de Nooijer, Inge Grondman, Simon Lambden, Emma J Kooistra, Nico AF Janssen, Matthijs Kox, et al. (+6)
21 [GO] Bioscience Reports 2021―Jun―16 Heparanase as a Potential Player in SARS-CoV-2 Infection and Induced-Coagulopathy Safa Kinaneh, Iyad Khamaysi, Tony Karram, Shadi Hamoud
22 [GO] Essays in Biochemistry 2021―May―24 3D Bioprinting for fabrication of tissue models of COVID-19 infection Anisha Kabir, Pallab Datta, Julia Oh, Adam Williams, Veli Ozbolat, Derya Unutmaz, Ibrahim T. Ozbolat
23 [GO] Clinical Science 2021―Apr―21 Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat? Fedor Simko, Tomas Baka
24 [GO] The Biochemist 2021―Apr―09 The COVID-19 pandemic: impact on the molecular bioscience research community and beyond Pedro Ferreira, Dominika Gruszka, Derry Mercer
25 [GO] Biochemical Society Transactions 2021―Mar―05 Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter? Devanshi Mishra, Chinmoy Sankar Dey
26 [GO] Bioscience Reports 2021―Feb―26 Lipidomic Alteration of Plasma in Cured COVID-19 Patients using UltraHigh-Performance Liquid Chromatography with High-Resolution Mass Spectrometry Yunpeng Bai, Wendong Huang, Yaocai Li, Changchun Lai, Sumei Huang, Guangwen Wang, et al. (+3)
27 [GO] Bioscience Reports 2021―Feb―24 Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates Mateus S.M. Serafim, Jadson C. Gertrudes, Débora M. A. Costa, Patricia R. Oliveira, Vinicius G. Maltarollo, Kathia Maria Honorio
28 [GO] Bioscience Reports 2021―Feb―24 The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage Junfang Wu, Mingming Zhao, Chenze Li, Yuxuan Zhang, Dao Wen Wang
29 [GO] Bioscience Reports 2021―Feb―23 Correction: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
30 [GO] Clinical Science 2021―Feb―06 ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders Xi Cao, Li-Ni Song, Jin-Kui Yang
31 [GO] Clinical Science 2021―Jan―29 ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease Jithin Kuriakose, Augusto C. Montezano, Rhian M. Touyz
32 [GO] Clinical Science 2021―Jan―23 Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19 Maria A Pedrosa, Rita Valenzuela, Pablo Garrido, Carmen M Labandeira, Gemma Navarro, Rafael Franco, et al. (+2)
33 [GO] Bioscience Reports 2021―Jan―23 Hyperglycaemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: A meta-analysis Yan Yang, Zixin Cai, Jingjing Zhang
34 [GO] Bioscience Reports 2021―Jan―14 ACE/ACE2 balance might be instrumental to explain the certain comorbidities lead to severe COVID-19 cases Sarbashri Bank, Subrata Kumar De, Biswabandhu Bankura, Smarajit Maiti, Madhusudan Das, Gausal A Khan
35 [GO] Biochemical Journal 2021―Jan―14 The role of chemical biology in the fight against SARS-CoV-2 George M. Burslem
36 [GO] Clinical Science 2021―Jan―07 Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases Ravindra K. Sharma, Jing Li, Suraj Krishnan, Elaine M. Richards, Mohan K. Raizada, Rajesh Mohandas
37 [GO] Biochemical Society Transactions 2020―Dec―24 Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies Ilaria Manfredonia, Danny Incarnato
38 [GO] Bioscience Reports 2020―Dec―22 Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19 Guolian Zhao, Yazhou Xu, Jing Li, Xiaoli Cui, Xiaowen Tan, Hongyue Zhang, Liyun Dang
39 [GO] The Biochemist 2020―Dec―12 Uncloaking the invisible killer and developing an antidote to SARS-CoV-2 Andre Watson
40 [GO] Clinical Science 2020―Dec―11 ACE2, a multifunctional protein - from cardiovascular regulation to COVID-19 Michael Bader, Anthony J. Turner, Natalia Alenina
41 [GO] Bioscience Reports 2020―Dec―11 Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential Zubair A Nizamudeen, Emma-Ruoqi Xu, Vivin Karthik, Mohamed Halawa, Kenton P Arkill, Andrew Jackson, et al. (+2)
42 [GO] Clinical Science 2020―Dec―09 ACE2: from protection of liver disease to propagation of COVID-19 Fiona J. Warner, Harinda Rajapaksha, Nicholas Shackel, Chandana B. Herath
43 [GO] The Biochemist 2020―Dec―09 Teaching and learning biochemistry in a pandemic (and beyond?) Chris Willmott
44 [GO] Emerging Topics in Life Sciences 2020―Dec―03 How SARS-CoV-2 (COVID-19) spreads within infected hosts - what we know so far Sumana Sanyal
45 [GO] Clinical Science 2020―Dec―03 Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists U. Muscha Steckelings, Colin Sumners
46 [GO] Emerging Topics in Life Sciences 2020―Dec―01 The zoonotic potential of bat-borne coronaviruses Ny Anjara Fifi Ravelomanantsoa, Sarah Guth, Angelo Andrianiaina, Santino Andry, Anecia Gentles, Hafaliana Christian Ranaivoson, Cara E. Brook
47 [GO] Biochemical Society Transactions 2020―Dec―01 A pocket guide on how to structure SARS-CoV-2 drugs and therapies Dene R. Littler, Bruce J. MacLachlan, Gabrielle M. Watson, Julian P. Vivian, Benjamin S. Gully
48 [GO] Bioscience Reports 2020―Nov―30 Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical Xi Zhou, Dong Chen, Lan Wang, Yuanyuan Zhao, Lai Wei, Zhishui Chen, Bo Yang
49 [GO] Clinical Science 2020―Nov―25 ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19 Koichi Yamamoto, Hikari Takeshita, Hiromi Rakugi
50 [GO] Emerging Topics in Life Sciences 2020―Nov―17 Endothelial pulsatile shear stress is a backstop for COVID-19 Marvin A. Sackner, Jose A. Adams
51 [GO] Bioscience Reports 2020―Nov―17 Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study. Gianluca E.M. Boari, Giulia Chiarini, Silvia Bonetti, Paolo Malerba, Gianluca Bianco, Cristina Faustini, et al. (+14)
52 [GO] Biochemical Society Transactions 2020―Nov―10 Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications Jiayue-Clara Jiang, Yan Zhang
53 [GO] Bioscience Reports 2020―Nov―04 Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6 Chun Liang, Wenhao Niu, Feng Wu, Wenyue Cao, Zonggui Wu, Yu Chieh Chao, Fei Peng
54 [GO] Clinical Science 2020―Nov―04 ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV Lizelle Lubbe, Gyles E. Cozier, Delia Oosthuizen, K. Ravi Acharya, Edward D. Sturrock
55 [GO] Clinical Science 2020―Nov―02 ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery Enrique Lores, Jan Wysocki, Daniel Batlle
56 [GO] Biochemical Society Transactions 2020―Oct―21 Transmission and prevention of SARS-CoV-2 Zhongyi Wang, Yingying Fu, Zhendong Guo, Jiaming Li, Jingjing Li, Hongliang Cheng, et al. (+2)
57 [GO] Bioscience Reports 2020―Oct―16 Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide? Abdulla A-B Badawy
58 [GO] Clinical Science 2020―Oct―16 Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease Carlos M. Ferrario, Sarfaraz Ahmad, Leanne Groban
59 [GO] The Biochemist 2020―Oct―12 Understanding the impact of COVID-19 on early career molecular bioscientists Dominika Gruszka
60 [GO] Clinical Science 2020―Sep―29 Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19 Nigel M. Hooper, Daniel W. Lambert, Anthony J. Turner
61 [GO] Clinical Science 2020―Sep―09 Correction: Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission
62 [GO] Clinical Science 2020―Sep―01 Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera Mohamad Aman Jairajpuri, Shoyab Ansari
63 [GO] Clinical Science 2020―Aug―21 Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission Daniella S. Battagello, Guilherme Dragunas, Marianne O. Klein, Ana L.P. Ayub, Fernando J. Velloso, Ricardo G. Correa
64 [GO] Clinical Science 2020―Aug―04 Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies Thiago Gomes Heck, Mirna Stela Ludwig, Matias Nunes Frizzo, Alberto Antonio Rasia-Filho, Paulo Ivo Homem de Bittencourt
65 [GO] Bioscience Reports 2020―Jul―29 Blood routine test in mild and common 2019 coronavirus (COVID-19) patients Dodji Kossi Djakpo, Zhiquan Wang, Rong Zhang, Xin Chen, Peng Chen, Malyn Martha Lilac ketisha Antoine
66 [GO] Clinical Science 2020―Jun―16 Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy Jameel M. Inal
67 [GO] Clinical Science 2020―Jun―16 SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure Alain R. Thierry, Benoit Roch
68 [GO] Biochemical Society Transactions 2020―Jun―08 α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19 Spencer J. Williams, Ethan D. Goddard-Borger
69 [GO] Clinical Science 2020―Jun―08 Covid-19: the renin-angiotensin system imbalance hypothesis Katharina Lanza, Lucas G. Perez, Larissa B. Costa, Thiago M. Cordeiro, Vitria A. Palmeira, Victor T. Ribeiro, Ana Cristina Simões e Silva
70 [GO] Bioscience Reports 2020―May―22 Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-19 Anas Shamsi, Taj Mohammad, Saleha Anwar, Mohamed Alajmi, Afzal Hussain, Md. Tabish Rehman, et al. (+2)
71 [GO] Clinical Science 2020―May―22 Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs Sayeed ur Rehman, Mohammad Tabish
72 [GO] Bioscience Reports 2020―May―07 A virus that has gone viral: Amino-acid mutation in S protein of Indian-isolate of Coronavirus COVID-19 might impact receptor-binding, thus infectivity Priyanka Saha, Arup Kumar Banerjee, Prem Prakash Tripathi, Amit Kumar Srivastava, Upasana Ray
73 [GO] Biochemical Journal 2020―Apr―29 Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle Samantha Gildenhuys
74 [GO] Clinical Science 2020―Apr―07 ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19 Rhian M. Touyz, Hongliang Li, Christian Delles
75 [GO] Clinical Science 2020―Mar―13 Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Daniel Batlle, Jan Wysocki, Karla Satchell
76 [GO] Biochemical Journal 2020―Feb―21 Processing of the SARS-CoV pp1a/ab nsp7-10 region Boris Krichel, Sven Falke, Rolf Hilgenfeld, Lars Redecke, Charlotte Uetrecht


Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.013 sec